Elonva Dosage & Drug Information

Concise Prescribing Info

Contents

Corifollitropin α

Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.

Indications/Uses

Controlled ovarian stimulation (COS) in combination w/ a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.

Dosage/Direction for Use

SC Administer Elonva on stimulation day 1, followed by a GnRH antagonist on day 5 or 6. Treatment may be continued w/ daily inj of recombinant FSH on day 8. Women >36 yr weighing ≥50 kg or >60 kg regardless of age 150 mcg as single dose, ≤36 yr weighing ≤60 kg 100 mcg as single dose.

Contraindications

Hypersensitivity. Ovarian, breast, uterine, pituitary or hypothalamic tumours. Abnormal vag bleeding w/o known diagnosed cause. Primary ovarian failure. Ovarian cysts or enlarged ovaries. History of ovarian hyperstimulation syndrome (OHSS); previous COS cycle resulted in >30 follicles ≥11 mm measured by ultrasound exam; basal antral follicle count >20; polycystic ovarian syndrome. Uterine fibroid tumours & reproductive organ malformations incompatible w/ pregnancy. Pregnancy.

MIMS Class

Trophic Hormones & Related Synthetic Drugs

ATC Classification

G03GA09 - corifollitropin alfa ; Belongs to the class of gonadotropins. Used as ovulation stimulants.

Regulatory Classification

POM

Presentation/Packing

Form

Elonva soln for inj 100 mcg/0.5 mL

Packing/Price

1's

Form

Elonva soln for inj 150 mcg/0.5 mL

Packing/Price

1's

Elonva

corifollitropin alfa

Manufacturer:

Organon